Identification and validation of predictive biomarkers (BM) for everolimus (EVE) in metastatic renal cell carcinoma: Analysis of 442 patients on RECORD-3 Meeting Abstract
| Authors: | Voss, M. H.; Chen, D.; Marker, M.; Hamilton, M.; Kalfoglou, C.; Hsieh, J.; Knox, J. J.; Anak, O.; Motzer, R. J. |
| Abstract Title: | Identification and validation of predictive biomarkers (BM) for everolimus (EVE) in metastatic renal cell carcinoma: Analysis of 442 patients on RECORD-3 |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203336 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4531 |
| Notes: | Meeting Abstract: 4531 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
